Caveolin-1, a stress-related oncotarget, in drug resistance

Oncotarget. 2015 Nov 10;6(35):37135-50. doi: 10.18632/oncotarget.5789.

Abstract

Caveolin-1 (Cav-1) is both a tumor suppressor and an oncoprotein. Cav-1 overexpression was frequently confirmed in advanced cancer stages and positively associated with ABC transporters, cancer stem cell populations, aerobic glycolysis activity and autophagy. Cav-1 was tied to various stresses including radiotherapy, fluid shear and oxidative stresses and ultraviolet exposure, and interacted with stress signals such as AMP-activated protein kinase. Finally, a Cav-1 fluctuation model during cancer development is provided and Cav-1 is suggested to be a stress signal and cytoprotective. Loss of Cav-1 may increase susceptibility to oncogenic events. However, research to explore the underlying molecular network between Cav-1 and stress signals is warranted.

Keywords: ABC transporters; Cav-1; aerobic glycolysis; cancer drug resistance; cancer stem cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Caveolin 1 / antagonists & inhibitors*
  • Drug Resistance, Neoplasm*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Oxidative Stress*

Substances

  • Caveolin 1